Connect with us

Foreign news

China approves emergency usage of COVID-19 vaccines, official says

Published

on

A Chinese health official Saturday confirmed the country authorized emergency usage of COVID-19 vaccines developed by some select domestic companies on July 22.

“We’ve drawn up a series of plan packages, including medical consent forms, side-effects monitoring plans, rescuing plans, compensation plans, to make sure the emergency use is well regulated and monitored,” Zheng Zhongwei, head of China’s coronavirus vaccine development task force told CCTV.

An emergency use authorization, which is based on Chinese vaccine management law, allows unapproved vaccine candidates to be used among people who are at high risk of getting infected on a limited period.

By first inoculating the special groups, like frontline medical workers and civil servants, the move is to ensure that a city can keep normal functions when a health crisis strikes, the law stated.

Similar authorizations have been legalized in many countries. For example, U.S. Food and Drug Administration allows unapproved medical products to be used in an emergency to diagnose, treat or prevent life-threatening disease or conditions.

The national agency has used several emergency use authorizations since the coronavirus outbreak as a way to get many diagnostic tests more quickly to the market than the normal procedures.

“We are planning to scale up the inoculating group to better prepare for a possible next wave in autumn and winter,” Zheng added.

A new coronavirus vaccine cultivated within insect cells by West China Hospital of Sichuan University in Chengdu has been approved for human trial, according to local government on Saturday.

Using insect cells to grow proteins for the coronavirus vaccine – a first in China – could speed up large-scale production, the Chengdu city government said in a notice on its official WeChat account.

Animal tests have shown promising results in preventing coronavirus infection, the notice said, and no obvious side effects have found.

According to China’s National Medical Products Administration, at least eight potential coronavirus vaccines have entered different stages of clinical trials.

In an interview with CCTV, Yang Xiaoming, chief scientist of China’s vaccine development and CEO of China National Biotec Group (CNBG) said they’ve signed agreements with many countries on inactivated vaccine clinical trials over the past few months.

“Over 20,000 people has been vaccinated,” Yang added, “Vaccine safety is well guaranteed; the effectiveness is being closely monitored.”

The company announced on late Friday Argentina joined Peru, Morocco and the United Arab Emirates (UAE) in approving Phase 3 clinical trials for their inactivated coronavirus vaccine.

The experimental vaccine by CNBG received approval from the UAE in June for a Phase 3 trial and has since recruited 15,000 volunteers, according to the company.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Foreign news

Court of Arbitration Declares Indus Waters Treaty Fully Operational Rejects India’s ‘Abeyance’

Published

on

Cyril Ogar

The Court of Arbitration has unanimously reaffirmed that the Indus Waters Treaty (IWT) remains fully in force, ruling that India cannot unilaterally place the 1960 agreement in “abeyance” or suspend its obligations under the treaty.

The decision represents a significant legal development in the longstanding dispute between India and Pakistan over the management and use of the Indus river system.

The Court’s finding addresses a fundamental issue at the heart of the dispute: whether either party can unilaterally suspend the treaty outside the legal framework agreed by both countries.

In its unanimous determination, the Court made clear that the IWT continues to bind both India and Pakistan and that its obligations cannot be set aside through a unilateral political declaration.

The ruling means India remains subject to the treaty provisions governing the use of the Western Rivers, including requirements relating to the design and operation of hydroelectric projects, as well as the dispute-resolution mechanisms established under the agreement.

The Court has also ordered interim measures concerning the Ratle Hydroelectric Plant, restricting specified construction activities while the broader dispute remains under consideration.

The measures are aimed at preserving the effectiveness of the arbitration process and preventing developments that could prejudice the outcome of the proceedings.

For Pakistan, the decision represents significant legal validation of its longstanding position that the IWT is a binding international agreement and contains no provision allowing either party to unilaterally place it in abeyance.

Pakistan has consistently maintained that disagreements over the treaty should be addressed through the institutional mechanisms established by the agreement, rather than through unilateral action.

The IWT provides a structured framework for resolving disputes through mechanisms including the Permanent Indus Commission, Neutral Expert and Court of Arbitration processes.

The latest ruling therefore reinforces the principle that treaty obligations cannot simply be disregarded because of deteriorating political relations between signatories.

The significance of the decision extends beyond the India-Pakistan dispute. It underscores the broader international-law principle that agreements governing shared rivers and other transboundary resources must be respected and disputes resolved through established legal and institutional channels.

The Indus river system supports agriculture, livelihoods, food security and communities across the region, making the stability of the treaty particularly important.

The ruling also highlights the distinction between seeking to amend an international agreement through mutually agreed procedures and attempting to alter its obligations unilaterally.

The IWT has endured wars, prolonged diplomatic tensions and periods of limited bilateral engagement. Its continued operation demonstrates the importance of rules-based mechanisms in managing shared resources when relations between neighbouring states become strained.

For Pakistan, the outcome provides an opportunity to frame the decision not merely as a bilateral legal victory, but as an affirmation of international law, treaty compliance and peaceful dispute resolution.

The central message from the ruling is clear: the Indus Waters Treaty remains in force, its obligations continue to bind both parties, and disputes concerning shared waters must be addressed through the legal mechanisms agreed by India and Pakistan.

Continue Reading

Trending

error

Enjoy this blog? Please spread the word :)